Seiwert T - Search Results

1

Identification of neoantigen-specific T cells and their targets: implications for immunotherapy of head and neck squamous cell carcinoma.

Ren L, Leisegang M, Deng B, Matsuda T, Kiyotani K, Kato T, Harada M, Park JH, Saloura V, Seiwert T, Vokes E, Agrawal N, Nakamura Y. Ren L, et al. Among authors: seiwert t. Oncoimmunology. 2019 Feb 6;8(4):e1568813. doi: 10.1080/2162402X.2019.1568813. eCollection 2019. Oncoimmunology. 2019. PMID: 30906664 Free PMC article.

2

Biomarkers predictive of response to pembrolizumab in head and neck cancer.

Pfister DG, Haddad RI, Worden FP, Weiss J, Mehra R, Chow LQM, Liu SV, Kang H, Saba NF, Wirth LJ, Sukari A, Massarelli E, Ayers M, Albright A, Webber AL, Mogg R, Lunceford J, Huang L, Cristescu R, Cheng J, Seiwert TY, Bauml JM. Pfister DG, et al. Cancer Med. 2023 Mar;12(6):6603-6614. doi: 10.1002/cam4.5434. Epub 2022 Dec 7. Cancer Med. 2023. PMID: 36479637 Free PMC article.

3

Complete response to alectinib in ALK-fusion metastatic salivary ductal carcinoma.

Adashek JJ, Sapkota S, de Castro Luna R, Seiwert TY. Adashek JJ, et al. NPJ Precis Oncol. 2023 Apr 11;7(1):36. doi: 10.1038/s41698-023-00378-9. NPJ Precis Oncol. 2023. PMID: 37041305 Free PMC article.

4

A phase I study of pemetrexed, carboplatin, and concurrent radiotherapy in patients with locally advanced or metastatic non-small cell lung or esophageal cancer.

Seiwert TY, Connell PP, Mauer AM, Hoffman PC, George CM, Szeto L, Salgia R, Posther KE, Nguyen B, Haraf DJ, Vokes EE. Seiwert TY, et al. Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):515-22. doi: 10.1158/1078-0432.CCR-06-1058. Clin Cancer Res. 2007. PMID: 17255273 Clinical Trial.

5

The concurrent chemoradiation paradigm--general principles.

Seiwert TY, Salama JK, Vokes EE. Seiwert TY, et al. Nat Clin Pract Oncol. 2007 Feb;4(2):86-100. doi: 10.1038/ncponc0714. Nat Clin Pract Oncol. 2007. PMID: 17259930 Review.

6

The chemoradiation paradigm in head and neck cancer.

Seiwert TY, Salama JK, Vokes EE. Seiwert TY, et al. Nat Clin Pract Oncol. 2007 Mar;4(3):156-71. doi: 10.1038/ncponc0750. Nat Clin Pract Oncol. 2007. PMID: 17327856 Review.

7

Chemoradiotherapy for locally advanced head and neck cancer.

Salama JK, Seiwert TY, Vokes EE. Salama JK, et al. J Clin Oncol. 2007 Sep 10;25(26):4118-26. doi: 10.1200/JCO.2007.12.2697. J Clin Oncol. 2007. PMID: 17827462 Review. No abstract available.

8

A phase I trial of docetaxel based induction and concomitant chemotherapy in patients with locally advanced head and neck cancer.

Seiwert TY, Cohen EE, Haraf DJ, Stenson K, Blair EA, Mauer A, Dekker A, Vokes EE. Seiwert TY, et al. Cancer Invest. 2007 Sep;25(6):435-44. doi: 10.1080/07357900701357993. Cancer Invest. 2007. PMID: 17882655 Clinical Trial.

9

Phase I study of bevacizumab added to fluorouracil- and hydroxyurea-based concomitant chemoradiotherapy for poor-prognosis head and neck cancer.

Seiwert TY, Haraf DJ, Cohen EE, Stenson K, Witt ME, Dekker A, Kocherginsky M, Weichselbaum RR, Chen HX, Vokes EE. Seiwert TY, et al. J Clin Oncol. 2008 Apr 1;26(10):1732-41. doi: 10.1200/JCO.2007.13.1706. J Clin Oncol. 2008. PMID: 18375903 Clinical Trial.

10

Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study.

Cohen EE, Davis DW, Karrison TG, Seiwert TY, Wong SJ, Nattam S, Kozloff MF, Clark JI, Yan DH, Liu W, Pierce C, Dancey JE, Stenson K, Blair E, Dekker A, Vokes EE. Cohen EE, et al. Lancet Oncol. 2009 Mar;10(3):247-57. doi: 10.1016/S1470-2045(09)70002-6. Epub 2009 Feb 7. Lancet Oncol. 2009. PMID: 19201650 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

145 results

Search Page

Filters